Pharmaceutical Areas Research Articles

Editor-in-Chief letter of introduction

I am honoured to begin my new role as Editor-in-Chief of the Journal of Pharmaceutical Health Services Research (JPHSR). As a political scientist, who has been actively engaged in the pharmaceutical health services research area for over twenty-five years, both as a researcher and as a policy practitioner, I hope to offer a perspective that will contribute to the rich multidisciplinary nature of the Journal. The research and policy issues that we examine in this space continue to be complex, critical to the health and welfare of populations, and relevant to health professionals and researchers throughout the globe. And while some of the JPHSR’s research articles may be focused on pharmaceutical health services research issues that are particular to a given country or region, very often, it is apparent that there are key lessons that transcend geographical borders. Knowledge sharing about best practices, lessons learned, and even lessons forgotten, across borders and cultures is critical here and where I expect the JPHSR can assume an even greater role in the years ahead.

Production of fungal chitosan and fabrication of fungal chitosan/polycaprolactone electrospun nanofibers for tissue engineering.

The present study investigated that chitosan production of Rhizopus oryzae NRRL 1526 and Aspergillus niger ATCC 16404. Fungal chitosans were characterized by scanning electron microscopy (SEM)-energy dispersive X-ray analysis, Fourier transform infrared spectroscopy (FTIR), differential scanning calorimeter and deacetylation degrees of fungal chitosans were determined. The percentage yield of Ro-chitosan and An-chitosan were determined as 18.6% and 12.5%, respectively. According to percentage of chitosan yield and the results of the characterization studies, chitosan that obtained from Rhizopus oryzae NRRL 1526 was selected for subsequent studies. Cytotoxicity of chitosan obtained from Rhizopus oryzae NRRL 1526 was determined by MTT assay on human dermal fibroblast cell line. Acording to results of the cytotoxicity test fungal chitosan was nontoxic on cells. The high cell viability was observed 375 μg/mL concentration at 24th, 48th h periods and at the 187.5μg/ml 72nd h periods on cells. The fungal chitosan obtained from Rhizopus oryzae NRRL 1526 was used to fabrication of electrospun nanofibers. Fungal chitosan based polymer solutions were prepared by adding different substances and different electrostatic spinning parameters were used to obtain most suitable nanofiber structure. Characterization studies of nanofibers were carried out by SEM, FTIR and X-ray diffraction. The most suitable nanofiber structure was determined as F4 formula. The nanofiber structure was evaluated to be thin, bead-free, uniform, flexible and easily remove from surface and taking the shape of the area. After the characterization analysis of fungal chitosan it was determined that the chitosan, which obtained from Rhizopus oryzae NRRL 1526 is actually chitosan polymer and this polymer is usable for pharmaceutical areas and biotechnological applications. The electrospun nanofiber that blends fungal chitosan and PCL polymers were fabricated successfully and that it can be used as fabrication wound dressing models. RESEARCH HIGHLIGHTS: Extraction of chitosan from Rhizopus oryzae NRRL 1526 and Aspergillus niger ATCC 16404 and characterization scanning electron microscopy-energy dispersive X-ray analysis, Fourier transform infrared spectroscopy, differential scanning calorimeter. Fabrication and characterization of the fungal chitosan/PCL electrospun nanofibers.

Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery-Skin and Blood-Brain Barrier.

Over the past few years, pharmaceutical and biomedical areas have made the most astounding accomplishments in the field of medicine, diagnostics and drug delivery. Nanotechnology-based tools have played a major role in this. The implementation of this multifaceted nanotechnology concept encourages the advancement of innovative strategies and materials for improving patient compliance. The plausible usage of nanotechnology in drug delivery prompts an extension of lipid-based nanocarriers with a special reference to barriers such as the skin and blood-brain barrier (BBB) that have been discussed in the given manuscript. The limited permeability of these two intriguing biological barriers restricts the penetration of active moieties through the skin and brain, resulting in futile outcomes in several related ailments. Lipid-based nanocarriers provide a possible solution to this problem by facilitating the penetration of drugs across these obstacles, which leads to improvements in their effectiveness. A special emphasis in this review is placed on the composition, mechanism of penetration and recent applications of these carriers. It also includes recent research and the latest findings in the form of patents and clinical trials in this field. The presented data demonstrate the capability of these carriers as potential drug delivery systems across the skin (referred to as topical, dermal and transdermal delivery) as well as to the brain, which can be exploited further for the development of safe and efficacious products.

Frontiers and Structural Transformations of the Global Pharmaceutical Market

Background. In order to achieve the technological sovereignty of the Russian Federation, the transformation of existing scientific reserves into in-demand technologies and technologically independent sectors of the economy, special attention is paid to the frontier areas of world science. At the same time, frontiers are understood as thematic areas on the basis of which Russian critical technologies will be developed in the import-saving paradigm. Aims the purpose of the study is to identify the most promising niches of the global pharmaceutical market and research areas focused on their expansion. Methods. Analysis of the volume of RD financing by the worlds leading pharmaceutical companies in the period 20152022, multi-criteria scientometric analysis and thematic mapping of the collection of the most highly cited reviews published in 20202022 and indexed in the Scopus database. Results. The analysis of the volume of RD financing by the worlds leading pharmaceutical companies in the period 20152022, and their average annual growth rates, was carried out. It is shown that with an annual increase in the corporate RD budget of 2.8%, by 2022 the total RD expenditures of key players in the global pharmaceutical market reached $182 billion per year. At the same time, 60% of these funds ($109.4 billion) fell in 2022 to the top 20 global pharmaceutical companies investing in the development of new medicines. For comparison, the internal costs of research and development of the Russian Federation are given, which, taking into account the GDP deflator as of 08.04.2022, are estimated at $48 billion, of which the amount of budget funding provided in 2023 for the priority direction of the Strategy of Scientific and Technological Development of the Russian Federation Transition to personalized medicine, high-tech healthcare and technologies health savings, including through the rational use of medicines (primarily antibacterial), will amount to 39.5 billion rubles. Given the relatively low level of funding for domestic research and development of new medicines (compared to the budgets for RD of pharmaceutical companies in the world), it seemed important to identify the most promising niches of the global pharmaceutical market and research areas focused on their expansion. Conclusion. As a result of multi-criteria scientometric analysis and thematic mapping of the collection of the most highly cited reviews published in 20202022 and indexed in the Scopus database, 10 frontier research areas have been identified that have the potential to transform the structure of the global pharmaceutical market until 2030.

A qualitative study on female executive pharmacists with convergent roles.

Although women's participation is relatively high in the pharmacist workforce, women remain underrepresented in executive positions. The rate of executive female pharmacists in diversified pharmaceutical areas, from education and research to politics, is recognized as being disproportionately low. In this study, we aimed to explore female executive pharmacists' roles and identify reasons for their being underrepresented in such executive positions in Turkey. Semistructured in-depth interviews were conducted from a feminist standpoint with female executive delegates working in the Grand National Assembly of Turkey, pharmacy chambers, and public pharmacy faculties. A thematic data analysis of transcriptions was conducted using MAXQDA 2020 software and was reported according to Consolidated Criteria for Reporting Qualitative Research. The researchers interviewed 19 participants. Three primary themes emerged: gender roles, being an executive, and being a pharmacist. Eight roles came to the surface: mother, child, wife, pharmacist, manager, homemaker, cook, and planner. Taking the responsibility for an executive position involves a continued and simultaneous performance of all other roles as well. In this context, female pharmacists' views on gender roles in relation to motherhood, inequalities, and their dedication to their profession came to the fore. This study can be considered as a starting point for studying the underlying causes of the limited representation of female pharmacists in executive positions.

Use of Artificial Intelligence in Drug Discovery and its Application in Drug Development

Artificial intelligence is an area of computer science that deals with the ability to solve problems using symbolic programming. Artificial intelligence can help solve health-care issues with large-scale applications. Expert system development is a significant and effective application of artificial intelligence. Artificial intelligence (AI) is a technology-based system that uses a variety of advanced tools and networks to simulate human intelligence. AI makes use of systems and software that can read and learn from data and to make independent judgments in order to achieve certain goals. Its applications in the pharmaceutical area are constantly being expanded, as discussed in this chapter. Recently, healthcare sector is facing some complex challenges, such as the increased cost of drugs and therapies, and society needs specific significant changes in this area. Personalized medications with the necessary dose, release parameters, and other required aspects can be manufactured according to individual patient need with the use of AI in pharmaceutical product manufacturing. Using the latest AI-based technologies will not only reduce the time it takes for products to reach the market, but it will also improve product quality and overall safety of the manufacturing process, as well as provide better resource utilization and cost-effectiveness, emphasize the importance of automation. This chapter emphasizes the importance of artificial intelligence (AI) in the pharmaceutical sector, including drug research and development, medication repurposing, enhancing pharmaceutical productivity, and clinical trials And its current and future applications in drug discovery development.

Antioxidant and Antidiabetic Activity of Algae.

Currently, algae arouse a growing interest in the pharmaceutical and cosmetic area due to the fact that they have a great diversity of bioactive compounds with the potential for pharmacological and nutraceutical applications. Due to lifestyle modifications brought on by rapid urbanization, diabetes mellitus, a metabolic illness, is the third largest cause of death globally. The hunt for an efficient natural-based antidiabetic therapy is crucial to battling diabetes and the associated consequences due to the unfavorable side effects of currently available antidiabetic medications. Finding the possible advantages of algae for the control of diabetes is crucial for the creation of natural drugs. Many of algae's metabolic processes produce bioactive secondary metabolites, which give algae their diverse chemical and biological features. Numerous studies have demonstrated the antioxidant and antidiabetic benefits of algae, mostly by blocking carbohydrate hydrolyzing enzyme activity, such as α-amylase and α-glucosidase. Additionally, bioactive components from algae can lessen diabetic symptoms in vivo. Therefore, the current review concentrates on the role of various secondary bioactive substances found naturally in algae and their potential as antioxidants and antidiabetic materials, as well as the urgent need to apply these substances in the pharmaceutical industry.

Nanoparticles: Taking a Unique Position in Medicine.

The human nature of curiosity, wonder, and ingenuity date back to the age of humankind. In parallel with our history of civilization, interest in scientific approaches to unravel mechanisms underlying natural phenomena has been developing. Recent years have witnessed unprecedented growth in research in the area of pharmaceuticals and medicine. The optimism that nanotechnology (NT) applied to medicine and drugs is taking serious steps to bring about significant advances in diagnosing, treating, and preventing disease-a shift from fantasy to reality. The growing interest in the future medical applications of NT leads to the emergence of a new field for nanomaterials (NMs) and biomedicine. In recent years, NMs have emerged as essential game players in modern medicine, with clinical applications ranging from contrast agents in imaging to carriers for drug and gene delivery into tumors. Indeed, there are instances where nanoparticles (NPs) enable analyses and therapies that cannot be performed otherwise. However, NPs also bring unique environmental and societal challenges, particularly concerning toxicity. Thus, clinical applications of NPs should be revisited, and a deep understanding of the effects of NPs from the pathophysiologic basis of a disease may bring more sophisticated diagnostic opportunities and yield more effective therapies and preventive features. Correspondingly, this review highlights the significant contributions of NPs to modern medicine and drug delivery systems. This study also attempted to glimpse the future impact of NT in medicine and pharmaceuticals.

Synergistic effect of silica nanoparticles assisted by rosemary powder in the stabilization of styrene-isoprene-styrene triblock copolymer

The synergistic efficiency in the improvement of thermal and radiation stabilities of polymer substrate (styrene-isoprene-styrene triblock copolymer) is studied by isothermal and nonisothermal chemiluminescence, when silica nanoparticles loaded in various proportions (1, 2, and 3 wt%) are coupled with rosemary in the dropping down the degradation rate. The measurements of chemiluminescence emission intensities at various degradation degrees obtained by accelerated ageing with γ-radiation provide the evidences for a synergistic action of n-silica nanoparticles/rosemary extract upon the stability of polymer matrix. The main kinetic parameter, oxidation induction time (OIT), which describes the stabilization efficiency of additives by the hindering of oxidation presents illustrative values for the co-operation factors between the two prevention components. The synergistic effect is evident: the OIT of couple action is much higher than the values that characterize component activities. This feature has much higher values than unity. The contribution of this inorganic/organic antioxidant couple is discussed based on the activation energy values calculated by Arrhenius method. The effects of silica nanoparticles on the delay of degradation is also analyzed by means of nonisothermal chemiluminescence measurements, which prove the increase of protection activity when the silica loading is enhanced from 1 to 3 wt%. The applications of this stabilization couple may be found in the areas of food handling, pharmaceutics, medical wear, dentistry, nuclear sealing, commodities, and many suitable others.

Propolis and Their Active Constituents for Chronic Diseases.

Propolis is a mass of chemically diverse phytoconstituents with gummy textures that are naturally produced by honeybees upon collection of plant resins for utilization in various life processes in beehives. Since ancient times, propolis has been a unique traditional remedy globally utilized for several purposes, and it has secured value in pharmaceutical and nutraceutical areas in recent years. The chemical composition of propolis comprises diverse constituents and deviations in the precise composition of the honeybee species, plant source used for propolis production by bees, climate conditions and harvesting season. Over 300 molecular structures have been discovered from propolis, and important classes include phenolic acids, flavonoids, terpenoids, benzofurans, benzopyrene and chalcones. Propolis has also been reported to have diverse pharmacological activities, such as antidiabetic, anti-inflammatory, antioxidant, anticancer, immunomodulatory, antibacterial, antiviral, antifungal, and anticaries. As chronic diseases have risen as a global health threat, abundant research has been conducted to track propolis and its constituents as alternative therapies for chronic diseases. Several clinical trials have also revealed the potency of propolis and its constituents for preventing and curing some chronic diseases. This review explores the beneficial effect of propolis and its active constituents with credible mechanisms and computational studies on chronic diseases.

Preparation, Purification and Characterization of Antibacterial and ACE Inhibitory Peptides from Head Protein Hydrolysate of Kuruma Shrimp, Marsupenaeus japonicus.

Kuruma shrimp (Marsupenaeus japonicus) heads, as the main by-product of the seafood processing industry, are rich in underutilized high-quality protein. After papain hydrolysis at 50 °C for 4 h, the protein hydrolysate of shrimp heads was found to show notable antibacterial and angiotensin I-converting enzyme (ACE) inhibitory activities. After purification using two stages of revered-phase high-performance liquid chromatography (RP-HPLC), the antibacterial peptide VTVP and the ACE inhibitory peptide ARL/I were successfully identified from most active fractions by LC-MS/MS. Peptide VTVP was a desirable hydrophobic peptide, with a MIC value in the range from 1.62 to 8.03 mM against all tested pathogens. Peptide ARL/I exhibited potent ACE inhibitory activity, with an IC50 value of 125.58 µM, and was found to be a competitive inhibitor based on the Lineweaver-Burk plot. Moreover, the result of the molecular docking simulation indicated that the interaction binding between ARL/I and ACE was mainly stabilized by hydrogen bonds, as well as forming a coordinate bond with the Zn2+ site. The purified peptides did not show hemolytic activity toward rabbit erythrocytes. To sum up, the bioactive peptides isolated from shrimp heads could be applicable for food or pharmaceutical areas as promising ingredients.

Ecosystem Services Provided by Seaweeds

The ecosystem services can be divided using two major classification systems, the Millennium Ecosystem Assessment (MEA) and the Common International Classification of Ecosystem Services (CICES). In the MEA system, the ecosystem services are divided into four major service clusters: supporting, provisioning, regulating, and cultural. On the other hand, the CICES system regards the “MEA supporting services” as organism natural function (and not an ecosystem service). Thus, this function is the basis for all the three CICES ecosystem services (provisioning, regulating, and cultural) provided by one organism. These ecosystem services can be analyzed for the type of habitat, fauna or flora. Seaweeds, or marine macroalgae, are one of the key organisms in estuarine and seawater habitats ecosystems, which currently is of extreme importance due to the climate changes and the blue–green economy. Seaweeds and humankind have been interlinked from the beginning, mainly as a food source, fibers, biochemicals, natural medicine, ornamental resources, art inspiration, and esthetic values in several coastal communities. Moreover, currently they are being studied as green carbon, carbon sequestration, and as a possible source for the biomedical and pharmaceutical areas. This review is a concise review of all ecological services provided by seaweeds and their impact in the human life and maintenance of the ecosystem status quo. The future of seaweeds use is also approached, regarding the promotion of seaweed ecological services and its dangers in the future.

Pharmaceutical Systems as a Strategy to Enhance the Stability of Oxytetracycline Hydrochloride Polymorphs in Solution

In order to improve the stability of oxytetracycline hydrochloride, a polymorphic antibiotic set of novel binary systems were developed using β-cyclodextrin and amino acids with different acid-basic characteristics as ligands. The formation constants for each system containing β-cyclodextrin, L-aspartic acid, histidine and N-acetylcysteine were determined by Scott's method and statistical studies. The structure of the binary systems with β-cyclodextrin and N-acetylcysteine was elucidated by NMR experiments. The effect β-cyclodextrin and N-acetylcysteine on the polymorph's chemical stability in aqueous and phosphate buffered saline solutions at 25 °C was monitored by an optimized and validated high-performance liquid chromatography method. The combination of N-acetylcysteine with the three polymorphs and the β-cyclodextrin system obtained with the form III demonstrated a reduction in the degradation rate of oxytetracycline hydrochloride in the aqueous solution when compared to each free form, with an increase of 20 h in the half time. It evidences that the use of amino acids as ligands constitutes an interesting alternative for pharmaceutical areas. In conclusion, based on the results obtained, these pharmaceutical systems could be candidates for the development of a pharmaceutical formulation for the administration of the drug through reconstituted solutions using the binary system as a promising tool for improving the stability of oxytetracycline hydrochloride polymorphs in solution.

Use of Conductivity as a Tool for On-site Residue Management and Definition of Smart Cleanroom Regimes

Surface residues that result from the use of cleaning and disinfection products are becoming an increasing focus of regulators in the Cleanroom industry. Driven largely by the update to EU GMP Annex 1 [1] and best practice recommendation from the PDA Journal of Pharmaceutical Science and Technology [2], it is now recognized that residues need to be managed to avoid any risks they could present to safety or product quality. Residue management can be successfully achieved by selection and use of low residue disinfectants, through the frequency and choice of rinsing agent for removal, the use of the most suitable tools for physical removal like cleanroom specific mops, or a combination of all these factors. Unlike product contact surfaces [3], there is no clear guidance as to what level of residue may be acceptable on small or large cleanroom surfaces, or how they can be quantified. For this reason, most people still rely on judging a surface to be ‘visibly clean’. To improve detection and to quantify the level of residue on a cleanroom surface, a pragmatic method has been developed to measure residue anywhere on-site: Quantification of disinfectant residues by the use of conductivity. The method of quantification of disinfectant residues using conductivity has been verified in studies by measuring the residues derived from different disinfectant types, at various scales (from bench scale upwards) and various locations, and from laboratory to representative pharmaceutical manufacturing areas. Compared to the current ‘gold standard’ that has long been used for the assessment of residues – an individual’s judgment of ‘visually clean’ - the data from conductivity measurements can eliminate this subjective human appraisal and replace it with scientific assessment. Comparison of the visual analysis rating versus conductivity data also revealed that the human eye does indeed underestimate the actual levels of disinfectant residues remaining on surfaces in a cleanroom, resulting in potential impacts of risk to safety, contamination, time, and cost.

Nutracêuticos à base de bagaços de uva portuguesa como potencial aditivo em produtos alimentares

Abstract Portuguese wine industry by-products are often undervalued but constitute a potential source of bioactive phenolic compounds that can be applied as a natural additive in several industries. In this context, the present study aimed to evaluate the nutritional composition, and the phenolic profile of two Portuguese Vitis vinifera L. grape pomaces (Touriga Nacional (red variety) and Alvarinho (white variety), and to correlate their chemical characterizations with their antioxidant activities. Strong correlations were observed between the presence of phenolic compounds and antioxidant activities, which enhances the application of pomace extracts in food and pharmaceutical areas. The high content of total phenolic compounds (25 - 41 g/ kg dry extract) and of flavonoids (9.2 - 18 g/ kg dry extract) found in both samples make these pomaces excellent candidates as food additives in food products, as well as antioxidant agents, such as natural dyes. Some polyphenols were identified by High Performance Liquid Chromatography (HPLC), being rutin and catequin the highest compounds found in red grape pomace (Touriga Nacional) while quercetin was only quantified in white grape pomace (Alvarinho). Cis-resveratrol was quantified in both grape pomace, which opens horizons for its use since this compound has considerable chemopreventive effects in the three main gains of carcinogenesis. As expected, the anthocyanin content was significantly higher in red grape pomace (37 g/ kg dry extract), emphasizing its interest as a natural food additive. Based on the findings, it is possible to conclude that these by-products have additional value, making them potentially useful in the food, pharmaceutical, and cosmetic industries.

Advances in the synthetic strategies of benzoxazoles using 2-aminophenol as a precursor: an up-to-date review.

Benzoxazole is a resourceful and important member of the heteroarenes that connects synthetic organic chemistry to medicinal, pharmaceutical, and industrial areas. It is a bicyclic planar molecule and is the most favorable moiety for researchers because it has been extensively used as a starting material for different mechanistic approaches in drug discovery. The motif exhibits a high possibility of broad substrate scope and functionalization to offer several biological activities like anti-microbial, anti-fungal, anti-cancer, anti-oxidant, anti-inflammatory effects, and so on. There has been a large upsurge in the synthesis of benzoxazole via different pathways. The present article presents recent advances in synthetic strategies for benzoxazole derivatives since 2018. A variety of well-organized synthetic methodologies for benzoxazole using 2-aminophenol with aldehydes, ketones, acids, alcohols, isothiocyanates, ortho-esters, and alkynones under different reaction conditions and catalysts, viz. nanocatalysts, metal catalysts, and ionic liquid catalysts, with other miscellaneous techniques has been summarized.

A SYSTEMATIC REVIEW OF SOFTWARE AND RESOURCES AVAILABLE IN THE PHARMACEUTICAL SECTOR

The whole pharmaceutical area (pharmacy industry, pharmacy billing, clinical trials, pharmacovigilance, and drug-drug interaction detection) needed various innovative and scientific solutions to solve the problems. A systematic review was performed on various software applications widely used in the pharmaceutical industry, including clinical trials, pharmacy billing, pharmacovigilance, the detection of drug interactions that assist the healthcare professional. Our review concluded that computer software has created a significant role in the pharmaceutical industry, pharmacy billing, and herbal industry. The computer software and programmes aid in reducing manufacturing costs, manufacturing errors, medical errors, and clinical errors.The software performs various safety functions, supplies on-screen access to pertinent drug and patient information, manages data, and assists in the product formulation process. The programmed safeguards can be modified to meet changing requirements.

Short Review on Metal Complexes of Schiff Bases containing Antibiotic, and Bioactivity Applications

In the fields of medicine and pharmaceuticals, a family of compounds known as Schiff bases (SB) plays an important part. Schiff base metal complexes are known to display a broad range of biological activities, each of which is unique in comparison to the others. Anticonvulsants, antibacterial agents, antifungal agents, anticancer agents, antiviral agents, and HIV-fighting medicines are all included in this area of pharmaceuticals. It is general information that the search for new medications and the creation of new medicines is a constant endeavor for scientists and researchers. This is true both in terms of the hunt for new medicines and the manufacturing of new medicines. Antibiotics are losing their effectiveness as microorganisms develop resistance to the drugs that treat them, thus there is a pressing need to discover new substances that might combat this problem. Because of this, the focus of this study was on Schiff bases that had just recently been identified, as well as the metal complexes of those bases that had these qualities.

Pfaffia glomerata: Gallic acid and phenolic compounds determination

Pfaffia glomerata, known as ginseng-brasileiro, is a root widely used in folk medicine, being effective against inflammation, rheumatism, and fatigue, in addition to present aphrodisiacs and antidiabetics properties. Among the classes of substances reported for the specie, the phenolic acids, in special gallic acid, has shown positive activity to learning and memory, having a considerable effect against neurotoxic and pro-oxidant substances. Therefore, the article’s objective was to quantify gallic acid in the chloroform and ethyl acetate fractions from P. glomerata. Thus, the aerial parts of ginseng were collected, dried and subjected to extraction with ethanol followed by fractionation with organic solvents in different polarities, obtaining the hexanic, dichloromethane (CHCl3) and ethyl acetate (AcOEt) fractions. Then, gallic acid was identified by TLC and quantified by HPLC in the ethyl acetate fraction. The total phenolic content was determined in the chloroform and ethyl acetate fractions, presenting values of 70,3 mg/g and 118,6 mg/g, respectively. The gallic acid content determined by HPLC in the AcOEt fraction was 904,15 µg/g, while in the CHCl3 fraction it was not possible to quantify. So, the species can be a source of phenolic compounds for possible applications in the pharmaceutical area.

Nickel‐Catalyzed Multicomponent Reactions: An Overview

AbstractMulticomponent reactions have received a lot of attention as a potential method for the synthesis of a wide range of complex organic molecules. Rapid development is being made in this field because of its importance in the chemical, pharmaceutical, biological, and industrial areas. Nickel is a versatile catalyst that can be used in a variety of synthetic transformations. In this review, we discuss the advancements in the field of Nickel‐catalyzed multicomponent reactions, covering the literature up to 2021.